MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SAINE, S. E.
Right arrow Articles by STROBEL, H. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SAINE, S. E.
Right arrow Articles by STROBEL, H. W.

Molecular Pharmacology, Vol 12, 649-657, Copyright © 1976 by the American Society for Pharmacology and Experimental Therapeutics

Drug Metabolism in Liver Tumors

Resolution of Components and Reconstitution of Activity

SUSAN E. SAINE 1 and HENRY W. STROBEL 1

1 Department of Biochemistry and Molecular Biology, The University of Texas Medical School at Houston, Houston, Texas 77030

The microsomal drug metabolism system has been resolved from Hepatoma 5123 t.c.(H) into its component enzymes: cytochrome P-450 and NADPH-cytochrome P-450 reductase. Reconstitution of benzphetamine hydroxylation activity with these two hepatoma proteins requires the presence of phosphatidylcholine. The hepatoma cytochrome P-450 has been purified 12-fold and can be substituted for liver cytochrome P-450 in a reconstituted system containing phosphatidylcholine and liver reductase. Hepatoma cytochrome P-450 reductase has been purified 130-fold. The purified reductase has an apparent minimum molecular weight of about 80,000 and is free of cytochromes P-450 and P-420. The purified reductase catalyzes electron transfer to the artificial electron acceptors cytochrome c, dichlorophenolindophenol, and ferricyanide; the Km concentrations required by the hepatoma reductase to generate half the maximal velocity for each acceptor are similar to those required by purified liver reductase. The Km value of the hepatoma reductase for NADPH (76 µM), however, is an order of magnitude higher than that of the purified liver reductase (7.8 µM). Hepatoma reductase can substitute for liver reductase in a reconstituted benzphetamine hydroxylation system containing liver cytochrome P-450 and phosphatidylcholine. Reconstitution of benzphetamine hydroxylation activity from hepatoma components was shown to require, like the liver system, the presence of both cytochrome P-450 and NADPH-cytochrome P-450 reductase, as well as phosphatidylcholine, to achieve the maximal hydroxylation rate. In a benzphetamine hydroxylation system containing liver cytochrome P-450, hepatoma cytochrome P-450 reductase, and phosphatidylcholine, the Km values for benzphetamine and NADPH were shown to be 390 and 15 µM, respectively. The value for benzphetamine is similar to that obtained in a reconstituted liver system, while the value for NADPH is an order of magnitude higher than that determined for the liven system.

Note:
ACKNOWLEDGMENTS We wish to acknowledge the skilled technical assistance of Mr. Tracy Lanagan.

Submitted on December 10, 1975







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1976 by the American Society for Pharmacology and Experimental Therapeutics